Skip to main content
    X

    Xtant Medical Holdings Inc (XTNT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • AMEX

    $0.20
    -0.01 (-3.43%)

    Market Cap: $38.12M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Xtant Medical Holdings Inc (XTNT) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Xtant Medical Holdings (XTNT) has a market cap of $38.12M and an enterprise value of $52.36M. Revenue fell 24.44% over the last 12 months from the 12 months before. It kept -15.92% of revenue as net income over the last 12 months.

    Total Valuation

    Enterprise value is 37.38% above the market cap, as debt exceeds cash.

    Market Cap$38.12M
    Enterprise Value$52.36M
    Latest price (Nov 17, 2026)$0.20

    Key Dates

    The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 29, 2027 (expected)
    Last Earnings DateNov 16, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.07% in the quarter ended Sep 30, 2026 and grew 1.93% a year over 2 years.

    Shares Outstanding140.36M
    Shares Change (YoY)+0.47%
    Shares Change (QoQ)+0.07%
    Share Count Growth (2Y CAGR)+1.93%

    Valuation Ratios

    Sales and book value multiples are 0.3x and 0.8x. Its year-end P/S ranged from 0.1x to 1.5x from 2017 to 2025.

    P/S Ratio0.3x
    Forward P/S0.4x
    P/B Ratio0.8x
    P/TBV Ratio0.9x

    Valuation history and multiples

    Price Statistics

    The stock is down 68.93% over 52 weeks and trades 35.48% below its 50-day average.

    Beta (1Y)0.58
    52-Week Change-68.93%
    1-Month Change-30.38%
    3-Month Change-38.62%
    6-Month Change-55.86%
    5-Year Change-75.63%
    10-Year Change-96.89%
    Total Return (1Y)-68.93%
    Total Return (3Y CAGR)-43.93%
    Max Drawdown (1Y)-74.99%
    Max Drawdown (3Y)-85.42%
    Sharpe Ratio (1Y)-1.69
    Correlation with SPY (1Y)0.12
    50-Day Average$0.31
    200-Day Average$0.44
    52-Week Range$0.17 to $0.84
    RSI (14 Days)22.2
    Average Volume (20 Days)230.03K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.00x current liabilities, and total debt is 0.59x shareholder equity.

    Current Ratio2.00x
    Quick Ratio0.93x
    Debt / Equity0.59x
    Interest Coverage2.88x

    Returns and Efficiency

    Return on invested capital is -20.35% over the last 12 months, against a 5-year average of -4.90%.

    Return on Equity (ROE)-42.96%
    Return on Assets (ROA)-21.28%
    Return on Invested Capital (ROIC)-20.35%
    Return on Capital Employed (ROCE)-26.84%
    ROE (5Y Average)-13.55%
    ROA (5Y Average)-6.90%
    ROIC (5Y Average)-4.90%
    Asset Turnover1.11x
    Inventory Turnover1.33x
    Receivables Turnover5.26x
    Cash Conversion Cycle295 days

    Scores

    XTNT has an Altman Z-Score of -3.29, in the distress zone below 1.81, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.

    Altman Z-Score-3.29
    Altman Z ZoneDistress
    Piotroski F-Score8 of 9
    Piotroski StrengthStrong

    Income Statement

    Revenue was $100.56M over the last 12 months.

    Revenue$100.56M
    Revenue Growth (YoY)-24.44%
    Gross Profit$56.72M
    Operating Income-$16.06M
    Pretax Income-$14.20M
    Net Income-$16.01M
    EBITDA-$8.72M
    EBIT-$12.07M
    Reported EPS (TTM)-$0.12

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 49.53% of the $75.22M in total assets.

    Cash and Equivalents$7.79M
    Total Debt$22.04M
    Net Debt$14.25M
    Net Debt Per Share$0.10
    Working Capital$30.33M
    Shareholder Equity$37.26M
    Book Value Per Share$0.27
    Tangible Book Value$30.96M
    Tangible Book Per Share$0.22
    Total Assets$75.22M
    Total Liabilities$37.96M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $1.23M of capital spending, operating cash flow left -$6.12M of free cash flow.

    Operating Cash Flow-$4.90M
    Capital Expenditures$1.23M
    Free Cash Flow-$6.12M
    FCF Per Share-$0.04
    Depreciation and Amortization$3.34M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -15.98%, against a 5-year average of -6.92%.

    Gross Margin56.40%
    Operating Margin-15.98%
    Pretax Margin-14.12%
    Net Margin-15.92%
    EBITDA Margin-8.67%
    EBIT Margin-12.00%
    FCF Margin-6.09%
    Gross Margin (5Y Average)59.22%
    Operating Margin (5Y Average)-6.92%
    Net Margin (5Y Average)-6.60%

    Growth

    Revenue grew 32.20% a year over 3 years.

    Revenue Growth (3Y CAGR)+32.20%
    Revenue Growth (5Y CAGR)+20.22%
    Book Value Per Share Growth (2Y CAGR)-7.34%
    Tangible Book Per Share Growth (2Y CAGR)+6.57%

    Revenue and profit by year

    Dividends and Yields

    XTNT does not pay a dividend. Its free cash flow yield is -21.53%.

    FCF Yield-21.53%
    Buyback Yield0.23%
    Shareholder Yield0.23%

    Stock Splits

    The last split was a 1-for-12 reverse split on Feb 14, 2018.

    Last Split DateFeb 14, 2018
    Split TypeReverse split
    Split Ratio1:12

    Peer Position

    Against 12 similar companies, XTNT has the 12th highest P/S.

    P/S Ratio0.3x vs 1.8x median
    ROIC-20.35% vs -77.64% median
    Revenue Growth (Trailing 4 Quarters, YoY)-24.44% vs +9.27% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -9.28% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-9.28%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About XTNT

    What is XTNT's market cap?

    Xtant Medical Holdings has a market cap of $38.12M. Its enterprise value, which adds debt and subtracts cash, is $52.36M.

    How many shares of XTNT are outstanding?

    Xtant Medical Holdings has 140.36M shares outstanding. The count is up 0.47% from a year earlier.

    Does XTNT pay a dividend?

    No. Xtant Medical Holdings does not pay a dividend.

    How much debt does XTNT have?

    Xtant Medical Holdings has $22.04M of total debt and $7.79M of cash and equivalents, a net debt position of $14.25M.